Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_provenance.
- NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_assertion description "[We sought to investigate the prognostic value of prostaglandin synthase 2 (PTGS2), cyclooxygenase 2 (COX2), thymidylate synthetase (TYMS), thymidine phosphorylase (TYMP), dihydropyrimidine dehydrogenase (DPYD) and topoisomerase I (TOPO1) in colorectal cancer patients treated with 5-FU-based regimens, such as De Gramont and FOLFOX in the adjuvant setting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_provenance.
- NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_assertion evidence source_evidence_literature NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_provenance.
- NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_assertion SIO_000772 25202077 NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_provenance.
- NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_assertion wasDerivedFrom befree-20150227 NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_provenance.
- NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_assertion wasGeneratedBy ECO_0000203 NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP358882.RAQi-nEqCeH-9Sv3J4B2-g5KRvx62bhlJowwgSymtT1KU130_provenance.